CLMT Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

1.21B

+27.8%

-0.420

+142.91%

1.14B

+15.17%

-0.070

-89.55%

1.15B

+12.28%

0.010

-102.5%

Estimates Revision

The market is revising Upward the revenue expectations for Calumet, Inc. (CLMT) for FY2025, with the revenue forecasts being adjusted by 0.84% over the past three months. During the same period, the stock price has changed by 9.30%.

Revenue Estimates for FY2025

Revise Upward

+0.84%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-91.07%

In Past 3 Month

Stock Price

Go Up

+9.30%

In Past 3 Month

4 Analyst Rating

Wall Street analysts forecast CLMT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLMT is 23.67 USD with a low forecast of 18.00 USD and a high forecast of 33.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

3 Buy

1 Hold

0 Sell

Strong Buy

Current: 0.000

Low

18.00

Averages

23.67

High

33.00

Current: 0.000

Low

18.00

Averages

23.67

High

33.00

TD Cowen

Hold

maintain

$15 -> $18

2025-11-11

Reason

TD Cowen

Price Target

$15 -> $18

2025-11-11

maintain

Hold

Reason

TD Cowen raised the firm's price target on Calumet to $18 from $15 and keeps a Hold rating on the shares. The firm said 3Q results reflected strong core business dynamics. MRL should improve in 4Q with lower feedstock costs. The company sees passage of 2026 RVO supporting industry margins next year.

Goldman Sachs

Buy

maintain

$15 -> $20

2025-10-22

Reason

Goldman Sachs

Price Target

$15 -> $20

2025-10-22

maintain

Buy

Reason

Goldman Sachs raised the firm's price target on Calumet to $20 from $15 and keeps a Buy rating on the shares.

UBS

Manav Gupta

Neutral

maintain

$12

2025-08-12

Reason

UBS

Manav Gupta

Price Target

$12

2025-08-12

maintain

Neutral

Reason

UBS analyst Manav Gupta raised the firm's price target on Calumet to $13.25 from $12 and keeps a Neutral rating on the shares.

BofA

Buy

maintain

$15 -> $20

2025-06-17

Reason

BofA

Price Target

$15 -> $20

2025-06-17

maintain

Buy

Reason

BofA raised the firm's price target on Calumet to $20 from $15 and keeps a Buy rating on the shares after the EPA proposed a total renewable volume obligation of 24.02B renewable identification numbers for 2026. The RVO is positive for Calumet, says the analyst, who notes that the higher RVO corresponds to a 20c per gallon higher margin on the cost curve than the firm's prior expectation. The firm raised its price target due to higher surety for demand and higher margins in the near-to-longer term, the analyst tells investors.

Wells Fargo

Overweight

downgrade

$23 -> $21

2025-05-14

Reason

Wells Fargo

Price Target

$23 -> $21

2025-05-14

downgrade

Overweight

Reason

Wells Fargo lowered the firm's price target on Calumet to $21 from $23 and keeps an Overweight rating on the shares. The firm says the Path to MaxSAF remains on schedule, but more importantly, significantly cheaper. Potential dispositions provide a bridge for any debt reduction, Wells adds.

BofA

Conor Fitzpatrick

Buy

initiated

$15

2025-05-13

Reason

BofA

Conor Fitzpatrick

Price Target

$15

2025-05-13

initiated

Buy

Reason

BofA analyst Conor Fitzpatrick initiated coverage of Calumet with a Buy rating and $15 price target. The oil refiner and biofuel producer is progressing its biofuel business Montana Renewables' MaxSAF project to expand renewable jet fuel capacity, notes the analyst, who expects MaxSAF to roughly double EBITDA between 2025 and 2027. Renewables growth should drive deleveraging, the analyst added.

Valuation Metrics

The current forward P/E ratio for Calumet Inc (CLMT.O) is -46.55, compared to its 5-year average forward P/E of -10.98. For a more detailed relative valuation and DCF analysis to assess Calumet Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-10.98

Current PE

-46.55

Overvalued PE

25.49

Undervalued PE

-47.44

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

10.84

Current EV/EBITDA

12.29

Overvalued EV/EBITDA

13.53

Undervalued EV/EBITDA

8.14

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

0.33

Current PS

0.39

Overvalued PS

0.45

Undervalued PS

0.22

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders areSelling! The selling amount has increased 12013.98% over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders areSelling! The selling amount has increased 12013.98% over the last month.

Sold

Bought

CLMT News & Events

Events Timeline

No data

News

8.5

01-07PRnewswire

PinnedCalumet Prices $405 Million Senior Notes Offering to Redeem Existing Debt

1.0

01-09PRnewswire

Calumet to Attend UBS Global Energy Conference and Hold Investor Meetings

1.0

01-09Newsfilter

Calumet to Attend UBS Global Energy Conference and Hold Investor Meetings

People Also Watch

Frequently Asked Questions

What is Calumet Inc (CLMT) stock price today?

The current price of CLMT is 19.87 USD — it has decreased -1.29 % in the last trading day.

What is Calumet Inc (CLMT)'s business?

Calumet, Inc. manufactures, formulates and markets a diversified slate of specialty branded products and renewable fuels to customers across a range of consumer-facing and industrial markets. Its segments include Specialty Products and Solutions; Performance Brands; Montana/Renewables, and Corporate. Specialty Products and Solutions segment manufactures and markets a variety of solvents, waxes, customized lubricating oils, white oils, petrolatum, gels, esters, and other products. Performance Brands segment blend, package and market high performance products through its Royal Purple, Bel-Ray, and TruFuel brands. Montana/Renewables segment comprises two facilities: renewable fuels and specialty asphalt. At its Montana Renewables facility, it processes a variety of geographically advantaged renewable feedstocks into renewable diesel, sustainable aviation fuel, renewable hydrogen, renewable natural gas, renewable propane, and renewable naphtha that are distributed into renewables markets.

What is the price predicton of CLMT Stock?

What is Calumet Inc (CLMT)'s revenue for the last quarter?

Calumet Inc revenue for the last quarter amounts to 1.08B USD, decreased -2.04 % YoY.

What is Calumet Inc (CLMT)'s earnings per share (EPS) for the last quarter?

Calumet Inc. EPS for the last quarter amounts to 3.61 USD, decreased -405.93 % YoY.

What changes have occurred in the market's expectations for Calumet Inc (CLMT)'s fundamentals?

How many employees does Calumet Inc (CLMT). have?

Calumet Inc (CLMT) has 1620 emplpoyees as of January 10 2026.

What is Calumet Inc (CLMT) market cap?

Today CLMT has the market capitalization of 1.72B USD.